Descrizione del progetto
Integrare la Cina nel consorzio internazionale per la medicina personalizzata (IC2PerMed)
Grazie ai progressi compiuti nel campo delle tecnologie biomediche e digitali, la medicina personalizzata migliora l’assistenza sanitaria e sostiene sistemi sanitari più efficienti e sostenibili. In Cina, essa sta suscitando un enorme interesse, con il governo che sfrutta la sua esperienza nel campo delle biotecnologie, dell’hardware di calcolo e della produzione di infrastrutture a sostegno dei progetti bioinformatici. Trasformare la medicina personalizzata in un’opportunità per i cittadini e i pazienti richiede l’impegno delle parti interessate a livello internazionale, al fine di definire approcci, standard e priorità comuni in materia di ricerca e sviluppo. Per rispondere a queste sfide, l’UE sostiene le azioni sviluppate nell’ambito del consorzio internazionale per la medicina personalizzata (ICPerMed). Il progetto IC2PerMed, finanziato dall’UE, fornirà soluzioni chiave per consentire la convergenza, nell’ambito di ICPerMed, delle parti interessate europee e cinesi verso un approccio comune di medicina personalizzata, coinvolgendo i responsabili politici e i beneficiari dei servizi sanitari.
Obiettivo
Personalised Medicine (PM) approaches, thanks to the latest technological advances notably in the fields of biomedical and digital technologies, prove their potential to improve healthcare and underpin more efficient and sustainable health systems.
PM is at the top of the European Commission research agenda, with funding devoted to projects along the entire value chain. In China, PM is attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and the ability to put in place the infrastructures for supporting large bioinformatics projects.
Turning PM into an opportunity for all citizens and patients requires the engagement of all stakeholders, in order to define common research and development approaches, standards, and priorities, and to scale up the collaboration at the International level. In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed).
IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed consortium of European and Chinese stakeholders towards a common approach of PM research, innovation, development and implementation involving policy makers and healthcare beneficiaries, by:
- mapping policies, programmes, standards and initiatives related to PM in Europe in China for identifying the opportunities for research collaborations;
- structuring its developments upon an ecosystem of European and Chinese experts, collaborating in Working Groups centred on ICPerMed Action plan priorities;
- setting bridges with key organisms involved in the definition and implementation of PM and healthcare systems in both economic areas, both on benefits for coordinated approaches for research and on concrete developments taking place within and along the project;
- inserting its developments in international contexts, through ICPerMed and its involvement in relevant initiatives and networks.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-2019-Single-Stage-RTD
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
20123 Milano
Italia